West Pharmaceutical Services (WST) Q1 2025 Earnings
West Pharmaceutical Services reported Q1 2025 revenue of $698.0M (+0.4% YoY), missed analyst consensus of $713.0M by $15.0M. Diluted EPS came in at $1.45 (-7.1% YoY), beat the $1.22 consensus by $0.23.
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about West Pharmaceutical Services's Q1 2025 earnings report.
West Pharmaceutical Services (WST) reported Q1 2025 earnings on April 24, 2025 before market open.
West Pharmaceutical Services reported revenue of $698.0M and diluted EPS of $1.45 for Q1 2025.
Revenue missed the consensus estimate of $713.0M by $15.0M. EPS beat the consensus estimate of $1.22 by $0.23.
Compared to the same quarter a year prior, revenue grew 0.4% from $695.4M a year earlier and diluted EPS declined 7.1% from $1.56.
You can read the 10-Q periodic report (0000105770-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.